9-May-2024
Solventum Corporation Non-GAAP EPS of $2.08 beats by $0.33, revenue of $2.01B beats by $40M
Seeking Alpha News (Thu, 9-May 7:12 AM ET)
Solventum Reports First Quarter 2024 Financial Results and Capital Allocation Update
PRNewswire (Thu, 9-May 6:50 AM ET)
Solventum Announces First Quarter 2024 Earnings Release Date and Upcoming Investor Events
PRNewswire (Tue, 23-Apr 4:45 PM ET)
Solventum Names Shirley Edwards to Board of Directors
PRNewswire (Mon, 15-Apr 6:30 AM ET)
Solventum Begins Trading on the New York Stock Exchange
PRNewswire (Mon, 1-Apr 6:30 AM ET)
Solventum is an independent healthcare?company with a primary focus on solving big healthcare challenges. Its diverse product portfolio spans across the healthcare industry from medical solutions and oral care to health information systems and separation and purification sciences.
Solventum trades on the NYSE stock market under the symbol SOLV.
As of May 9, 2024, SOLV stock price declined to $64.83 with 3,008,963 million shares trading.
SOLV has a market cap of $11.20 billion. This is considered a Large Cap stock.
The top ETF exchange traded funds that SOLV belongs to (by Net Assets): SPY, IVV, COWZ, XLV, QUAL.
SOLV support price is $64.98 and resistance is $67.88 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SOLV stock will trade within this expected range on the day.